Emerging concepts for pelvic organ prolapse surgery: What is cure?

被引：26

作者：

Lee U. ^{[1
]}

Raz S. ^{[1
]}

机构：

[1] Female Urology, Pelvic Medicine, and Reconstructive Surgery, Department of Urology, UCLA School of Medicine, Los Angeles, CA 90095

来源：

Current Urology Reports | 2011年 / 12卷 / 1期

关键词：

Cystocele; Female pelvic floor dysfunction; Pelvic organ prolapse; Quality of life; Surgical outcomes; Translabial ultrasound; Vaginal mesh;

D O I：

10.1007/s11934-010-0160-2

中图分类号：

学科分类号：

摘要：

The objective of this review is to discuss emerging concepts in pelvic organ prolapse, in particular, "What is cure?" In a post-trial data analysis of the CARE (Colpopexy and Urinary Reduction Efforts) trial, treatment success varied tremendously depending on the definition used (19.2%-97.2%). Definitions that included the absence of vaginal bulge symptoms had the strongest relationships with the patients' assessment of overall improvement and treatment success. As demonstrated by this study, there are several challenges in defining cure in prolapse surgery. Additionally, the symptoms of prolapse are variable. The degree of prolapse does not correlate directly with symptoms. There are many surgical approaches to pelvic organ prolapse. Multiple ways to quantify prolapse are used. There is a lack of standardized definition of cure. The data on prolapse surgery outcomes are heterogeneous. The goal of surgical repair is to return the pelvic organs to their original anatomic positions. Ideally, we have four main goals: no anatomic prolapse, no functional symptoms, patient satisfaction, and the avoidance of complications. The impact of transvaginal mesh requires thoughtful investigation. The driving force should be patient symptoms in defining cure of prolapse. © 2010 The Author(s).

引用

页码：62 / 67

页数：5

共 30 条

[1]

Swift S., Woodman P., O'Boyle A., Kahn M., Valley M., Bland D., Wang W., Schaffer J., Pelvic Organ Support Study (POSST): The distribution, clinical definition, and epidemiologic condition of pelvic organ support defects, American Journal of Obstetrics and Gynecology, 192, 3, pp. 795-806, (2005)

[2]

Olsen A.L., Smith V.J., Bergstrom J.O., Colling J.C., Clark A.L., Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence, Obstetrics and Gynecology, 89, 4, pp. 501-506, (1997)

[3]

Brown J.S., Waetjen L.E., Subak L.L., Thom D.H., Van Den Eeden S., Vittinghoff E., Pelvic organ prolapse surgery in the United States, 1997, American Journal of Obstetrics and Gynecology, 186, 4, pp. 712-716, (2002)

[4]

Subak L.L., Waetjen L.E., Van Den Eeden S., Thom D.H., Vittinghoff E., Brown J.S., Cost of pelvic organ prolapse surgery in the United States, Obstetrics and Gynecology, 98, 4, pp. 646-651, (2001)

[5]

Barber M.D., Brubaker L., Nygaard I., Et al., Pelvic floor disorders network: Defining success after surgery for pelvic organ prolapse, Obstet Gynecol, 114, 3, pp. 600-9, (2009)

[6]

Weber A.M., Abrams P., Brubaker L., Et al., The standardization of terminology for researchers in female pelvic floor disorders, Int Urogynecol J Pelvic Floor Dysfunct., 12, 3, pp. 178-86, (2001)

[7]

Ellerkmann R.M., Cundiff G.W., Melick C.F., Nihira M.A., Leffler K., Bent A.E., Correlation of symptoms with location and severity of pelvic organ prolapse, American Journal of Obstetrics and Gynecology, 185, 6, pp. 1332-1338, (2001)

[8]

Burrows L.J., Meyn L.A., Walters M.D., Weber A.M., Pelvic symptoms in women with pelvic organ prolapse, Obstetrics and Gynecology, 104, 5 I, pp. 982-988, (2004)

[9]

Ghetti C., Gregory W.T., Edwards S.R., Otto L.N., Clark A.L., Pelvic organ descent and symptoms of pelvic floor disorders, American Journal of Obstetrics and Gynecology, 193, 1, pp. 53-57, (2005)

[10]

Tan J.S., Lukacz E.S., Menefee S.A., Powell C.R., Nager C.W., Albo M.E., Luber K.M., Predictive value of prolapse symptoms: A large database study, International Urogynecology Journal and Pelvic Floor Dysfunction, 16, 3, pp. 203-209, (2005)

← 1 2 3 →